Glycogen synthase kinase 3β inhibitor, composition and process for the preparation thereof
US7179832B2 · kind B2 · utility
0Cited by
3References
6Claims
0Family size
Assignees
Inventors
Key dates
| Filing date | Jan 20, 2004 |
| Grant date | Feb 20, 2007 |
| Priority date | — |
| Expiry date | Jan 20, 2024 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC07D409/12
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
Novel compounds having hydroxybenzoimidazole carboxylic amide are useful for inhibiting glycogen synthase kinase 3β(GSK-3β).
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.